当前位置:首页 > 成功案例 > 北京太洋药业有限公司

北京太洋药业有限公司


北京太洋药业有限公司

北京太洋药业有限公司是一家现代化中外合资制药企业,创建于1992年,由鼎晖投资有限公司、新加坡政府投资公司、荷兰国家投资银行、香港名利集团、韩国三星公司等数家知名投资银行投资组成。太洋药业1998年被评为全国医药系统先进集体,被北京市连续四年认定为高新技术企业,已成为北京市医药行业的骨干企业。 太洋药业拥有完善的研发、生产体系,公司药物研究所被北京市经委认定为市级企业技术中心。高度自动化的专业车间通过了国家药品生产质量管理规范——GMP的认证。严格的质量保障体系和的控制检测手段以及优良的药物生产环境是太洋药业药品质量的可靠保证。太洋药业的科研人员利用生物信息科学、组合化学和生物医学,极大地推动了新药的研究和开发工作。

Beijing Taiyang Pharmaceutical Co., Ltd. is a modern joint venture pharmaceutical enterprise, founded in 1992. It is composed of several well-known investment institutions, including CDH Investment Co., Ltd., Singapore Government Investment Co., Ltd., Dutch National Investment Bank, Hong Kong Mingli group and SAMSUNG. In 1998, Taiyang pharmaceutical was rated as the advanced group of the national pharmaceutical system, and was recognized as a high-tech enterprise by Beijing for four consecutive years. It has become the backbone enterprise of the pharmaceutical industry in Beijing. Taiyang pharmaceutical has a complete R&D and production system, and its pharmaceutical research institute has been recognized as a municipal enterprise technology center by Beijing Economic Commission. The highly automated professional workshop has passed the GMP certification. Strict quality assurance system and control testing means as well as excellent drug production environment are the reliable guarantee for the drug quality of Taiyang pharmaceutical. Researchers in Taiyang have greatly promoted the research and development of new drugs by using bioinformatics, combinatorial chemistry and biomedicine.


http://932034.b2b.tfsb.cn/


0.173304s